Tootian Sameeramis, Mahjoubi Frouzandeh, Rahnama Mitra, Hormozian Fabyola, Mortezapour Farzaneh, Razazian Faegeh, Manoochehri Farnoosh, Zamanian Mahsa, Nasiri Fatemeh, Soleymani Saeedeh, Seyedmortaz Ladan
Research Centre of Iranian Blood Transfusion Organization, Hemmat Avenue, Tehran, Iran.
J Pediatr Hematol Oncol. 2006 Dec;28(12):834-6. doi: 10.1097/MPH.0b013e31802d3e1d.
We present our study on 318 patients suspected with Fanconi anemia (FA) referred to The Iranian Blood Transfusion Organization during the period of 4 years. Mitomycin C (MMC) was used as a DNA cross-linker to study chromosomal breakage. In total 61 positive cases were diagnosed cytogenetically. The ratio of women being affected was slightly higher than men. Comparison of several hematologic and clinical parameters in FA (MMC positive) and non-FA (MMC negative) patients showed no clinically significant differences. This study also indicates that this sort of test is very useful and essential for accurate diagnosis of patients with FA with or without congenital anomalies.
我们展示了我们对在4年期间转诊至伊朗输血组织的318例疑似范可尼贫血(FA)患者的研究。丝裂霉素C(MMC)被用作DNA交联剂来研究染色体断裂。总共通过细胞遗传学诊断出61例阳性病例。受影响女性的比例略高于男性。对FA(MMC阳性)和非FA(MMC阴性)患者的几个血液学和临床参数进行比较,未发现临床上的显著差异。这项研究还表明,这种检测对于准确诊断有无先天性异常的FA患者非常有用且必不可少。